Assignee

Exelixis, Inc.

Patents = 172

Trademarks = 18

Forward Citations = 1,442

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

407 inventors (with patents filed for the assignee):

Exelixis, Inc. is a biotechnology company focused on the discovery, development and commercialization of new medicines to improve the treatment of cancer and other serious diseases. With a robust pipeline of potential therapies, Exelixis is committed to advancing science to develop innovative treatments that can make a meaningful difference in patients' lives.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com